You have held CAJ before..
So kicking yourself for selling your shares in CAJ yet? Hmm..
You make valid points here but it is the 'hype' or 'estimated potential' of the coy that initially drives the share price to a reasonable support level as is forming here.
This is the first step toward commercial Bioprinting by the only current Aussie player in the market. The industry is set to grow quickly. News articles abound and have been building over the last few years. Of course diagnostic use requires approvals. That will be a major milestone and a positive to watch for over the coming months.
There are multiple revenue streams being generated from multiple parties we just don't know the details.. Yet..
Yes, the devil is in the detail. So where's the potential?
Ummm.. It's kind of staring you in the face don't you think?
Thanks for the reality check but I'm of the opinion 3DM has more than enough potential to run north of current SP. I won't be jumping ship anytime soon!